Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Prestige Consumer Healthcare (PBH) Accumulated Expenses (2016 - 2025)

Prestige Consumer Healthcare has reported Accumulated Expenses over the past 15 years, most recently at $15.1 million for Q4 2025.

  • Quarterly results put Accumulated Expenses at $15.1 million for Q4 2025, down 75.25% from a year ago — trailing twelve months through Dec 2025 was $15.1 million (down 75.25% YoY), and the annual figure for FY2025 was $63.5 million, up 13.01%.
  • Accumulated Expenses for Q4 2025 was $15.1 million at Prestige Consumer Healthcare, down from $68.5 million in the prior quarter.
  • Over the last five years, Accumulated Expenses for PBH hit a ceiling of $78.6 million in Q3 2021 and a floor of $15.1 million in Q4 2025.
  • Median Accumulated Expenses over the past 5 years was $60.5 million (2023), compared with a mean of $50.0 million.
  • Biggest five-year swings in Accumulated Expenses: surged 946.57% in 2021 and later plummeted 80.05% in 2022.
  • Prestige Consumer Healthcare's Accumulated Expenses stood at $71.0 million in 2021, then decreased by 0.01% to $71.0 million in 2022, then fell by 8.34% to $65.1 million in 2023, then decreased by 6.38% to $60.9 million in 2024, then crashed by 75.25% to $15.1 million in 2025.
  • The last three reported values for Accumulated Expenses were $15.1 million (Q4 2025), $68.5 million (Q3 2025), and $63.8 million (Q2 2025) per Business Quant data.